Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection? - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Autoimmunity Reviews Année : 2019

Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?

Résumé

Letter to the Editor

Dates et versions

inserm-02455417 , version 1 (26-01-2020)

Identifiants

Citer

Anupama Karnam, Emmanuel Stephen-Victor, Mrinmoy Das, Laurent Magy, Jean-Michel Vallat, et al.. Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?. Autoimmunity Reviews, 2019, 18 (6), pp.632-633. ⟨10.1016/j.autrev.2019.01.004⟩. ⟨inserm-02455417⟩
64 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More